RBC Transfusion in Severe Anemia With Lactic Acidosis
Phase 3
Completed
- Conditions
- Anemia
- Registration Number
- NCT01586923
- Lead Sponsor
- Massachusetts General Hospital
- Brief Summary
The hypothesis of this study is that prolonged-storage RBCs are not inferior to short-storage RBCs for the time required to clear elevated blood lactate levels in children with severe anemia.
- Detailed Description
This study will measure the time to resolution of lactic acidosis in patients with severe anemia following blood transfusion.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 290
Inclusion Criteria
- Age 6 mos to 5 years
- Hg < 5 g/dL and Lactate > 5 mM
Exclusion Criteria
- Receiving transfusion other than RBCs
- Children with known or suspected cardiac disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Reduction of elevated levels of blood lactate during 24 following RBC transfusion 24 hours
- Secondary Outcome Measures
Name Time Method Correction of acidosis 24 hours Normalization of vital signs 24 hours
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link prolonged-storage RBCs to lactate clearance in severe anemia?
How does prolonged-storage RBC transfusion compare to standard-of-care in resolving lactic acidosis in pediatric anemia?
Which biomarkers predict response to RBC transfusion efficacy in lactic acidosis resolution for severe anemia?
What adverse events are associated with prolonged-storage RBC transfusion in children with lactic acidosis?
Are there alternative RBC storage solutions or combination therapies improving outcomes in severe anemic lactic acidosis?
Trial Locations
- Locations (1)
Mulago Hospital
🇺🇬Kampala, Uganda
Mulago Hospital🇺🇬Kampala, Uganda